Vitiligo is a skin condition which causes patchy loss of skin pigmentation. Vitiligo affects 0.2% to 1 % of the people around the world. Vitiligo affect any location of the body where in the skin doesn’t have its characteristics color because melanin of the skin is lost. Vitiligo is usually caused in all the races equally but is more noticeable in dark skinned people. People carrying gene with vitiligo, sunburn and exposure to certain chemical and mechanical trauma have high risk of developing vitiligo. Also people with autoimmune disease, such as alopecia areata or Hashimoto’s disease, are at an increased risk of developing vitiligo. According to the American Academy of Dermatology Skin Disease, vitiligo is one among the 24 skin disease. More than 150,000 Americans across all age were treated for vitiligo in 2013 and the cost of healthcare was over $328 per patient which is three times over rosacea and twice more than acne.
Increasing disease prevalence for vitiligo, changing lifestyle, growing awareness among populations are the factors which drive the market of vitiligo treatment. Furthermore, availability of appropriate treatment, development of new novel therapy and drug discovery, undergoing clinical trial by various manufacturer spur the market of vitiligo treatment in the near future. Growing importance of aesthetic appeal, growing disposable income especially in emerging countries is expected to boost the vitiligo treatment market in forecast period. However poor patience adherence, high cost of treatment and stringent regulation for the drug development are the factors which hinder the growth of vitiligo treatment market.
Get Sample Copy of this report at https://www.persistencemarketresearch.com/samples/27958?source=atm
The global Vitiligo Treatment market is segmented on basis of Type, Drug Type, Distribution Channel, and Geography. Segmentation by Type Nonsegmental vitiligo Segmental vitiligo
Segmentation by Treatment Type Therapy Depigmentation Light Therapy Surgery Skin grafting Blister grafting Micro pigmentation Drug Type Topical Corticosteroids Xeljanz Immunosuppressive drug
Segmentation by Distribution Channel Institutional Sales Hospitals Dermatology Clinics Aesthetic Clinics Retail Sales Hospitals Pharmacies Retail Stores Drug Stores
Emergence of new therapy for skin disorders such as light therapy and various other invasive procedures fuels the vitiligo treatment market. Development of novel topical treatment containing human growth factor and cytokines is expected to boost the market in the near future. High demand for phototherapy, increased adoption of cosmetic procedures and other dermatology procedures spur the vitiligo treatment market. Growing per capita healthcare expenditure, improving healthcare infrastructure in emerging countries, growing disease awareness and presence of strong pipeline drive the vitiligo treatment market in forecast period.
The North America market contributes for the largest revenue share for Vitiligo Treatment, owing to growing prevalence of skin disorder such as vitiligo, rising adoption of phototherapy treatment options and high disposable income. Europe is expected to contribute for the second large revenue share in the global vitiligo treatment market, owing to presence of key manufacturers and increasing research and development funding along with the undergoing rigorous clinical trial. Asia Pacific is expected to show rapid growth, owing to increasing adoption of new technology and drug, increasing government funding and increasing medical tourism in countries such as Thailand, India, Singapore, South Korea, and Malaysia. China is expected to register fast growth, due to high patient population and adoption of cosmetic procedures for the vitiligo treatment market and rapid development of skin care industry. Latin America and Middle East & Africa is expected to show sluggish growth in vitiligo treatment market, due to less developed healthcare infrastructure and lack of skilled physicians.
Request Report Methodology at https://www.persistencemarketresearch.com/methodology/27958?source=atm
Examples of some of the key manufacturer present in the global Vitiligo Treatment market are Novartis AG, Allergan, Inc., Clinuvel Pharmaceuticals Limited, Eli Lilly Company, Incyte Corporation, AstraZeneca AB and Epizyme, Inc., among others.
The report covers exhaustive analysis on, Vitiligo Treatment Market Segments Vitiligo Treatment Market Dynamics Historical Actual Market Size, 2012 – 2016 Vitiligo Treatment Market Size & Forecast 2016 to 2024 Vitiligo Treatment Market Current Trends/Issues/Challenges Competition & Companies involved Vitiligo Treatment Market Drivers and Restraints
Regional analysis includes: North America Latin America Europe Asia Pacific Excluding China China Middle East & Africa
Report Highlights: Shifting Industry dynamics In-depth market segmentation Historical, current and projected industry size Recent industry trends Key Competition landscape Strategies of key players and product offerings Potential and niche segments/regions exhibiting promising growth A neutral perspective towards market performance
Request to view TOC at https://www.persistencemarketresearch.com/toc/27958?source=atm
This post was originally published on Space Market Research